Our aim was to determine how Ramadan fasting effects serum Human NAD-dependent deacetylase sirtuin 1 (SIRT1/SIR2L1) and visfatin levels during pregnancy.
Thirty-six patients were included in this case-control study. The patient group consisted of 18 pregnant women who were Ramadan fasting. Another healthy 18 pregnant women with matching pregnancy weeks and ages formed the control group. Blood samples were obtained from the patients for biochemical analyses and serum adipokine level measurements.
The mean sirtuin and visfatin levels in fasting pregnant women were 2.87 ± 0.95 and 60.18 ± 19.49 ng/mL, respectively, while the mean serum sirtuin and visfatin levels in the control group was determined to be 4.28 ± 1.45 and 23.26 ± 6.18 ng/mL, respectively. A statistically significant difference was determined between the groups (p = 0.002, p = 0.0001). A correlation analysis provided a negative correlation between number of fasting days and sirtuin levels (r = 0.45, p = 0.005) and a positive correlation with visfatin levels (r = 0.73, p = 0.0001).
As a result, while the serum sirtuin 1 level of pregnant women decreased due to fasting in Ramadan, we determined that their visfatin levels increased and this increase was in correlation with the days of fasting.
Azizi F : Research in Islamic fasting and health. Ann Saudi Med 22(3–4), 4487–4488 (2002)
Aziz AR , Slater GJ, Chia MYH, Teh KC: Effects of fasting on training induced adaptations to a seven-week high-intensity interval exercise programme. Sci Sports 27(1), 4487–4488 (2012)
BaHammam A , Alrajeh M, Albabtain M, Bahammam S, Sharif M: Circadian pattern of sleep, energy expenditure, and body temperature of young healthy men during the intermittent fasting of Ramadan. Appetite 54(2), 4487–4488 (2010)
Azizi F : Islamic fasting and health. Ann Nutr Metab 56(4), 4487–4488 (2010)
Van Ewijk R : Long-term health effects on the generation of Ramadan fasting during pregnancy. J Health Econ 30(6), 4487–4488 (2011)
Bener A , Galadari S, Gillett M, Osman N, Al-Taneiji H, Al-Kuwaiti MHH, Al-Sabosy MMA: Fasting during the holy month of Ramadan does not change the composition of breast milk. Nutr Res 21(6), 4487–4488 (2001)
Malhotra A , Scott PH, Scott J, Gee H, Wharton BA: Metabolic changes in Asian Muslim pregnant mothers observing the Ramadan fast in Britain. Br J Nutr 61(3), 4487–4488 (1989)
Dikensoy E , Balat O, Cebesoy B, Ozkur A, Cicek H, Can G: The effect of Ramadan fasting on maternal serum lipids, cortisol levels and fetal development. Arch Gynecol Obstet 279(2), 4487–4488 (2009)
Ichikawa T , Hayashi R, Suzuki K, Imanishi S, Kambara K, Okazawa S, Inomata M, Yamada T, Yamazaki Y, Koshimizu Y, Miwa T, Matsui S, Usui I, Urakaze M, Matsuya Y, Sasahara M, Tobe K: Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma. Respirology 18(2), 4487–4488 (2013)
Haberland M , Montgomery RL, Olson EN: The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10(1), 4487–4488 (2009)
Shakespear MR , Halili MA, Irvine KM, Fairlie DP, Sweet MJ: Histone deacetylases as regulators of inflammation and immunity. Trends Immunol 32(7), 4487–4488 (2011)
Osborne B , Cooney GJ, Turner N: Are sirtuin deacylase enzymes important modulators of mitochondrialenergy metabolism? Biochim Biophys Acta 1840(4), 4487–4488 (2014)
Haigis MC , Guarente LP: Mammalian sirtuins –emerging roles in physiology, aging, and calorie restriction. Genes Dev 20(21), 4487–4488 (2006)
Grubisha O , Smith BC, Denu JM: Small molecule regulation of Sir2 protein deacetylases. FEBS J 272(18), 4487–4488 (2005)
Rodgers JT , Puigserver P: Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci USA 104(31), 4487–4488 (2007)
Schug TT , Xu Q, Gao H, Peres-da-Silva A, Draper DW, Fessler MB, Purushotham A, Li X: Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol 30(19), 4487–4488 (2010)
Sun C , Zhang, F, Ge X, Yan T, Chen X, Shi X, Zhai Q: SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6(4), 4487–4488 (2007)
Jurdana M , Petelin A, Bizjak MC, Bizjak M, Biolo G, Jenko-Praznikar Z: Increased serum visfatin levels in obesity and its association with anthropometric/biochemical parameters, physical inactivity and nutrition. e-SPEN J 8, 4487–4488 (2013)
Saboori S , Hosseinzadeh-Attar MJ, Yousefirad E, M. Hosseini M, Mirzaei K, Ahmadivand Z: The comparison of serum vaspin and visfatin concentrations in obese and normal weight women. Diabetes Metab Syndr 9(4), 4487–4488 (2015)
Bourque SL , Dolinsky VW, Dyck JRB, Davidge ST: Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia. Placenta 33, 4487–4488 (2012)
Yoshino J , Mills KF, Yoon MJ, Imai S: Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14(4), 4487–4488 (2011)
Jiang WJ : Sirtuins: Novel targets for metabolic disease in drug development. Biochem and Biophys Res Commun 373(3), 4487–4488 (2008)
Schug TT , Li X: Sirtuin 1 in lipid metalism and obesity. Ann Med 43(3), 4487–4488 (2011)
Pfluger PT , Herranz D, Velasco-Miguel S, Serrano M, Tschöp MH: Sirt 1 protects against high-fat diet-induced metabolic damage. Proc Nat Acad Sci 105(28), 4487–4488 (2008)
Lomb DJ , Laurent G, Haigis MC: Sirtuins regulate key aspects of lipid metabolism. Biochim Biophys Acta 1804(8), 4487–4488 (2010)
Morgan SA , Bringolf JB, Seidel ER: Visfatin expression is elevated in normal human pregnancy. Peptides 29(8), 4487–4488 (2008)
Krzyzanowska K , Krugluger W, Mittermayer F, Rahma R, Haider D, Shnawa N: Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci 1, 4487–4488 (2006)
FU Cahn TF , Chen L, Kee CH, Chou FH, Wu LC, Jong SB, Tsai EM: Decreased plasma visfatin concentration in women with gestational diabetes mellitus. J Soc Gynecol Investig 13, 4487–4488 (2006)
Zhaoxia L , Ying W, Danqing C: Changes in visfatin levels after oral glucose tolerance test in women with gestational diabetes mellitus. Diabetes Res Clin Pract 96, 4487–4488 (2012)
de Luis DA , Gonzalez Sagrado M, Conde R, Aller R, Izaola O: Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose. Nutrition 29(11–12), 4487–4488 (2013)
Feldt-Rasmussen U , Mathiesen ER: Endocrine disorders in pregnancy: physiological and hormonal aspects of pregnancy. Best Pract Res Clin Endocrinol Metab 25(6), 4487–4488 (2011)
Kiziltan G , Karabudak E, Tuncay G, Avsar F, Tuncay P, Mungan O, Meral P: Dietary intake and nutritional status of Turkish pregnant women during Ramadan. Saudi Med J 26(11), 4487–4488 (2005)